2011
DOI: 10.4238/2011.november.29.9
|View full text |Cite
|
Sign up to set email alerts
|

Neuroprotective effects of NEP1-40 and fasudil on Nogo-A expression in neonatal rats with hypoxic-ischemic brain damage

Abstract: ABSTRACT. The hypoxic-ischemic encephalopathy caused by peripartum asphyxia is a serious disease in newborn infants, and effective therapies need to be developed to reduce injury-related disorders. We evaluated the effects of NEP1-40 and fasudil on Nogo-A expression in neonatal hypoxic-ischemic brain damage (HIBD) rats. Seven-day-old Wistar rats were randomly divided into control, HIBD, NEP1-40, and fasudil groups. NEP1-40 and fasudil groups were injected intraperitoneally with these compounds. Rat brains at 6… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…Nogo-66 inhibits activity-dependent axonal growth by binding to the Nogo-66 receptor-1 (NgR1) ( 20 ). In turn, the NgR1 competitive antagonist, NEP1-40 (Nogo-66, residues 1–40), and antibodies against NogoA block this inhibitory effect and improve the neurological outcomes following ischemic stroke in adult rats ( 21 , 22 ). Lysophosphatidic acid (LPA) is a bioactive lipid ( 23 ).…”
Section: Introductionmentioning
confidence: 99%
“…Nogo-66 inhibits activity-dependent axonal growth by binding to the Nogo-66 receptor-1 (NgR1) ( 20 ). In turn, the NgR1 competitive antagonist, NEP1-40 (Nogo-66, residues 1–40), and antibodies against NogoA block this inhibitory effect and improve the neurological outcomes following ischemic stroke in adult rats ( 21 , 22 ). Lysophosphatidic acid (LPA) is a bioactive lipid ( 23 ).…”
Section: Introductionmentioning
confidence: 99%
“…A number of factors contribute to nerve injury-associated diseases ( 1 3 ). Among these, spinal cord injury (SCI)-induced nerve damage is a serious threat to health worldwide ( 4 ). Following SCI, patients experience continuous and often diverse neurological deficits and disability ( 5 , 6 ).…”
Section: Introductionmentioning
confidence: 99%
“…While amino-Nogo is important in axonal regeneration, sprouting and new network formation (35), Nogo-66 inhibits activity-dependent axonal growth by binding to the Nogo-66 receptor-1 (NgR1) (5). In turn, the NgR1 competitive antagonist, NEP1-40 (Nogo-66 residues 1–40), blocks this inhibitory effect (6). Notably, antibodies against Nogo-A improve neurological outcomes following ischemic stroke in adult rats (7).…”
Section: Introductionmentioning
confidence: 99%